Sionna Therapeutics, Inc.
SION · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $766 | $461 | $1,103 |
| - Cash | $51 | $41 | $83 | $38 |
| + Debt | $8 | $9 | $9 | $10 |
| Enterprise Value | – | $734 | $388 | $1,075 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$20 | -$18 | -$19 | -$18 |
| % Margin | – | – | – | – |
| Net Income | -$20 | -$18 | -$16 | -$16 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.456 | -0.41 | -0.374 | -0.359 |
| % Growth | -11.2% | -9.7% | -4.1% | – |
| Operating Cash Flow | -$15 | -$18 | -$16 | -$12 |
| Capital Expenditures | -$0 | $0 | -$0 | $0 |
| Free Cash Flow | -$15 | -$18 | -$16 | -$12 |